Biochemical alternation caused by bovine respiratory disease and ceftiofur | ||||
| Suez Canal Veterinary Medical Journal. SCVMJ | ||||
| Articles in Press, Accepted Manuscript, Available Online from 28 May 2024 | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/scvmj.2024.286861.1168 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Rasha Al-awseya   1; Elsayed Gabr2; Mostafa Hassan3; Waleed Fathy Khalil 4; Abdelfattah Mohammed Abdelfattah5
| ||||
| 1Department of Pharmacology, Faculty of veterinary Medicine, Suez Canal University, Ismailia, Egypt. | ||||
| 2Department of Pharmacology, Faculty of Veterinary Medicine, Mansoura University, Mansoura, Egypt. | ||||
| 3Professor of pharmacology, Faculty of Veterinary Medicine, Suez Canal University | ||||
| 4Professor of Pharmacology Faculty of Veterinary Medicine, Suez Canal University | ||||
| 5Department of Pharmacology, Faculty of veterinary medicine, Suez Canal University | ||||
| Abstract | ||||
| The most prevalent and dangerous disease in herds that raise calves is bovine respiratory disease (BRD). Ceftiofur, third-generation cephalosporin antibiotic, has been approved for use in cattle in the United States. This study was done to investigate the biochemical alternation of the BRD and the effectiveness of ceftiofur. Thirty Holstein calves in a dairy farm were divided in to 3 groups. Group I was utilized as a healthy negative group. Group II was composed of healthy animals injected with ceftiofur (2mg/kg B.W) subcutaneously in the ear as single dose. Group III, clinically investigated to be suffering from BRD, was given ceftiofur with the same dose and administration route as group II. All groups were clinically evaluated at day 0, 7, and 14 after drug administration for illness score, Biochemical analysis showed significant (P | ||||
| Keywords | ||||
| Bovine respiratory disease; effectiveness; Ceftiofur; Calves; biochemical marks | ||||
|
Statistics Article View: 110 |
||||
